Valiant Laboratories Limited (VALIANTLAB.NS)
INR 93.1
(4.51%)
INR 93.1
(4.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 750.89 Million INR | 25.06% |
| 2022 | 600.42 Million INR | 0.63% |
| 2021 | 596.67 Million INR | 17871.99% |
| 2020 | 3.32 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 750.89 Million INR | 0.0% |
| 2023 FY | 750.89 Million INR | 25.06% |
| 2023 Q2 | 599.85 Million INR | 0.0% |
| 2023 Q1 | 599.85 Million INR | -0.09% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 600.42 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -19.418% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -598.303% |
| FDC Limited | 2.46 Million INR | -30350.081% |
| Gufic Biosciences Limited | 1.53 Billion INR | 51.229% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 97.629% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 46.482% |
| Orchid Pharma Limited | 1.2 Billion INR | 37.648% |
| Alkem Laboratories Limited | 400 Million INR | -87.725% |
| Bajaj HealthCare Limited | 650.34 Million INR | -15.462% |
| Brooks Laboratories Limited | 3.56 Million INR | -20963.086% |
| Eris Lifesciences Limited | 6.54 Billion INR | 88.527% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -408.705% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | 36.061% |
| Innova Captab Limited | 2.1 Billion INR | 64.331% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -893.647% |
| Wanbury Limited | 820 Million INR | 8.427% |
| Lupin Limited | 1.55 Billion INR | 51.642% |
| Aarti Drugs Limited | 2.75 Billion INR | 72.727% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -187624.75% |
| Albert David Limited | 6.01 Million INR | -12381.699% |
| Alembic Limited | 73.9 Million INR | -916.101% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Hester Biosciences Limited | 1.81 Billion INR | 58.69% |
| Hikal Limited | 4.22 Billion INR | 82.242% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -572.692% |
| Ind-Swift Limited | 10.09 Billion INR | 92.562% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -462.298% |
| Medico Remedies Limited | 8.67 Million INR | -8558.891% |
| Morepen Laboratories Limited | 33.64 Million INR | -2132.161% |
| Procter & Gamble Health Limited | 68.8 Million INR | -991.423% |
| RPG Life Sciences Limited | -30.3 Million INR | 2578.215% |
| Sigachi Industries Limited | 265.79 Million INR | -182.507% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -5545.857% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -253.604% |
| Themis Medicare Limited | 267.74 Million INR | -180.458% |
| Unichem Laboratories Limited | 382.22 Million INR | -96.457% |
| Vaishali Pharma Limited | 35.98 Million INR | -1986.816% |
| Venus Remedies Limited | 386.8 Million INR | -94.131% |
| Windlas Biotech Limited | 20.18 Million INR | -3621.006% |
| ZIM Laboratories Limited | 356 Million INR | -110.923% |
| Sakar Healthcare Limited | 549.55 Million INR | -36.639% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 96.483% |
| Divi's Laboratories Limited | 20 Million INR | -3654.495% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -2597.582% |
| Mankind Pharma Limited | 325.81 Million INR | -130.468% |
| Sequent Scientific Limited | 1.42 Billion INR | 47.386% |
| Laurus Labs Limited | 7.98 Billion INR | 90.593% |
| Neuland Laboratories Limited | 449.2 Million INR | -67.161% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -217.639% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 50.498% |
| Zydus Lifesciences Limited | 251 Million INR | -199.163% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -5275.852% |
| Wockhardt Limited | 8.91 Billion INR | 91.572% |
| Bal Pharma Limited | 363.82 Million INR | -106.391% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 87.464% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -110.973% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -8061.946% |
| Shilpa Medicare Limited | 5.6 Billion INR | 86.595% |
| Ajanta Pharma Limited | 235.2 Million INR | -219.26% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -2228.819% |
| Granules India Limited | 689.71 Million INR | -8.872% |
| Medicamen Biotech Limited | 12.55 Million INR | -5880.876% |
| Ipca Laboratories Limited | 5.8 Billion INR | 87.063% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 61699.59% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.86% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 95.319% |
| NATCO Pharma Limited | 53 Million INR | -1316.791% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 59.079% |
| Strides Pharma Science Limited | 6.71 Billion INR | 88.818% |
| Indoco Remedies Limited | 3.51 Billion INR | 78.651% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -604.408% |